Zevra Therapeutics (1GDA.F) Q2 2026 Earnings

May 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.16
0.54
1.24
1.94

Details

Expected EPS
0.069025461
Actual EPS
0.5105999999999999
Surprise EPS
0.44
Surprise Percent
+639.73%

Description

⁨Zevra Therapeutics⁩ (⁦1GDA.F⁩) has reported earnings of ⁦0.5105999999999999⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts